All posts by: Michael Zand

About Michael Zand

Is Alzheimer’s treatment of injecting stem cells into the brain a breakthrough or quackery? – The Mercury News

Continue reading

2017-03-06 NEWS

The Mercury News

Is Alzheimer’s treatment of injecting stem cells into the brain a breakthrough or quackery?
The Mercury News
Jack Sage has been receiving an experimental treatment in which a doctor injects stem cells into his brain to treat his Alzheimer’s disease. (Photo by Paul Rodriguez, Orange County Register/SCNG). Expand. By Keith Sharon, The Orange County Register |.

Continue reading

2017-03-06 NEWS

Applied StemCell Announces the Appointment of Dr. Michele Calos, Stanford Professor and Vice President of the …
Yahoo Finance
Applied StemCell (ASC), a leading stem cell and genome-editing company with a goal to advance genome editing and stem cell technologies for biomedical research and clinical applications, welcomes Dr. Michele Calos as a member of the company’s …

and more »

Continue reading

2017-03-06 NEWS

Epicutaneous Immunotherapy Shows Promise Against Peanut Allergy
Monthly Prescribing Reference (registration)
ATLANTA, GA—Epicutaneous immunotherapy (EPIT) treatment of peanut allergy with Viaskin® Peanut (VP) shows long-term safety and efficacy, according to findings from a 2-year open-label extension phase of the VIPES Phase 2b study, presented at the …

and more »

Continue reading

2017-03-06 NEWS

FOX 61

Sickle cell anemia patient ‘cured’ by gene therapy, doctors say
FOX 61
In a world first, a teenager with sickle cell disease achieved complete remission after an experimental gene therapy at Necker Children’s Hospital in Paris, researchers say. People with sickle-cell disease, a group of inherited blood disorders, have
In a first, gene therapy cures teen with sickle cell diseaseEconomic Times
Case Report: Sickle Cell Disease Gene TherapyRare Disease Report
Sickle cell reversed with gene therapy in teenagerBioNews
Fox News –ScienceAlert –BBC News –New England Journal of Medicine
all 76 news articles »
Continue reading

2017-03-06 NEWS

BRIEF-Advaxis announces FDA acceptance of IND for groundbreaking personalized neoepitope immunotherapy
Reuters
Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news …